(Q36619898)

15 August 2017

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions (English)

1 reference

15 August 2017

Miédougé M

1

1 reference

15 August 2017

Rouzaud P

2

1 reference

15 August 2017

Salama G

3

1 reference

15 August 2017

Pujazon MC

4

1 reference

15 August 2017

Vincent C

5

1 reference

15 August 2017

Mauduyt MA

6

1 reference

15 August 2017

Reyre J

7

1 reference

15 August 2017

Carles P

8

1 reference

15 August 2017

Serre G

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

81

1 reference

15 August 2017

6

1 reference

15 August 2017

1059-1065

1 reference

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Metastases of unknown primary site

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Thoracoscopy: present diagnostic and therapeutic indications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

CA 72-4 serum marker--a new tool in the management of carcinoma patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Diagnosis and management of malignant pleural effusions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Continuing increase in mesothelioma mortality in Britain.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

The Diagnostic and Therapeutic Utility of Thoracoscopy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical tumour markers in lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical Characteristics of the Patient with Nonspecific Pleuritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

State of the art. The pleura

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Immunophenotyping of Mesothelial Cells and Carcinoma Cells With Monoclonal Antibodies to Cytokeratins, Vimentin, Cea and Ema Improves the Cytodiagnosis of Serous Effusions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Carcinoembryonic Antigen Levels in Benign and Malignant Pleural Effusions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Prostatic adenocarcinoma diagnosed by prostate-specific antigen analysis of pleural fluid

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

20 September 2018

1 reference

12 December 2020

Simultaneous enzyme immunoassay of carcinoembryonic antigen in pleural effusion and serum

1 reference

12 December 2020

Clinical evaluation of CYFRA 21-1 in malignant pleural fluids

1 reference

12 December 2020

Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up

1 reference

12 December 2020

Evaluation of CYFRA 21-1 in malignant and benign pleural effusions

1 reference

12 December 2020

Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients

1 reference

12 December 2020

Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis

1 reference

12 December 2020

Evolution of Idiopathic Pleural Effusion

1 reference

12 December 2020

Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125

1 reference

12 December 2020

CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions

1 reference

12 December 2020

Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions

1 reference

12 December 2020

Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients

1 reference

12 December 2020

Tumor markers in the diagnosis of malignant serous effusions

1 reference

12 December 2020

Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations

1 reference

12 December 2020

False-positive results of carcinoembryonic antigen in pleural effusions

1 reference

12 December 2020

Ca 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers

1 reference

12 December 2020

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

1 reference

12 December 2020

Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels

1 reference

12 December 2020

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases

1 reference

12 December 2020

Carcinoembryonic antigen in pleural effusions: A diagnostic and prognostic indicator

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690807

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10576665

1 reference